PT3458448T - Inibidores fasn para uso no tratamento de esteato-hepatite não-alcoólica - Google Patents

Inibidores fasn para uso no tratamento de esteato-hepatite não-alcoólica

Info

Publication number
PT3458448T
PT3458448T PT177902871T PT17790287T PT3458448T PT 3458448 T PT3458448 T PT 3458448T PT 177902871 T PT177902871 T PT 177902871T PT 17790287 T PT17790287 T PT 17790287T PT 3458448 T PT3458448 T PT 3458448T
Authority
PT
Portugal
Prior art keywords
methods
fasn inhibitors
fasn
inhibitors
Prior art date
Application number
PT177902871T
Other languages
English (en)
Original Assignee
Forma Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forma Therapeutics Inc filed Critical Forma Therapeutics Inc
Publication of PT3458448T publication Critical patent/PT3458448T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
PT177902871T 2016-04-25 2017-04-25 Inibidores fasn para uso no tratamento de esteato-hepatite não-alcoólica PT3458448T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662327167P 2016-04-25 2016-04-25

Publications (1)

Publication Number Publication Date
PT3458448T true PT3458448T (pt) 2021-09-10

Family

ID=60157111

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177902871T PT3458448T (pt) 2016-04-25 2017-04-25 Inibidores fasn para uso no tratamento de esteato-hepatite não-alcoólica

Country Status (9)

Country Link
US (2) US20170312273A1 (pt)
EP (1) EP3458448B1 (pt)
DK (1) DK3458448T3 (pt)
ES (1) ES2886935T3 (pt)
MA (1) MA45047A (pt)
PL (1) PL3458448T3 (pt)
PT (1) PT3458448T (pt)
TW (1) TW201737943A (pt)
WO (1) WO2017189613A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2737434C2 (ru) 2013-03-13 2020-11-30 Форма Терапьютикс, Инк. Новые соединения и композиции для ингибирования fasn
NZ755835A (en) 2017-01-17 2023-12-22 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
WO2020092376A1 (en) * 2018-10-29 2020-05-07 Forma Therapeutics, Inc. Treating non-alcoholic steatohepatitis (nash)
US10793554B2 (en) * 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
CN113265468B (zh) * 2021-07-21 2021-10-12 北京大学第三医院（北京大学第三临床医学院） 一种与宫颈癌诊断、治疗和预后相关的miRNA
WO2023093700A1 (zh) * 2021-11-29 2023-06-01 中国海洋大学 咪唑并噻唑衍生物及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
CN101720434A (zh) * 2007-02-27 2010-06-02 菲思根诊断学有限公司 肝病中的脂肪酸合酶
RU2737434C2 (ru) * 2013-03-13 2020-11-30 Форма Терапьютикс, Инк. Новые соединения и композиции для ингибирования fasn
CN105008329B (zh) 2013-03-21 2018-01-05 默克专利股份公司 作为fasn抑制剂的哌嗪衍生物
WO2015084606A1 (en) * 2013-12-03 2015-06-11 Janssen Pharmaceutica Nv Benzamide derivative useful as fasn inhibitors for the treatment of cancer
JP6617106B2 (ja) * 2013-12-17 2019-12-04 ヤンセン ファーマシューティカ エヌ．ベー． 癌の治療用のｆａｓｎ阻害剤として有用なイミダゾリン−５−オン誘導体

Also Published As

Publication number Publication date
WO2017189613A1 (en) 2017-11-02
US20170312273A1 (en) 2017-11-02
US20190374536A1 (en) 2019-12-12
EP3458448B1 (en) 2021-06-23
EP3458448A4 (en) 2019-04-17
PL3458448T3 (pl) 2021-12-06
TW201737943A (zh) 2017-11-01
DK3458448T3 (da) 2021-08-23
MA45047A (fr) 2019-03-27
ES2886935T3 (es) 2021-12-21
EP3458448A1 (en) 2019-03-27

Similar Documents

Publication Publication Date Title
IL283267A (en) Inhibitors of menin–mll interaction
IL259560A (en) Inhibitors of the menin-mll interaction
EP3541932A4 (en) CRISPR-CAS9 INHIBITORS
PL3512850T3 (pl) Inhibitory interakcji menina-mll
IL251584B (en) Dihydropyrrolopyridines ror–gamma inhibitors
IL246902A0 (en) Dihydropyrrolopyridine ror–gamma inhibitors
IL279949A (en) Heterocyclic MCT4 inhibitors
IL257061A (en) Inhibitors of ezh2
PT3458448T (pt) Inibidores fasn para uso no tratamento de esteato-hepatite não-alcoólica
EP3405477C0 (en) INHIBITORS OF TRANSGLUTAMINASE
GB201521059D0 (en) Inhibitors of metallo-beta-lactamases
GB201612860D0 (en) Inhibitors
GB201708457D0 (en) Inhibitors of metallo-beta-lactamases
GB201708451D0 (en) Inhibitors of metallo-beta-lactamases
AU2015903172A0 (en) Inhibitors of necroptosis
AU2015900416A0 (en) Inhibitors of necroptosis